The report covers forecast and analysis for the Substance Abuse Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Substance Abuse Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Substance Abuse Treatment market on a global level. In order to give the users of this report a comprehensive view on the Substance Abuse Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Abuse Type, Treatment Type, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
According to the report, global demand for meningococcal vaccines Market was valued at approximately USD 14.44 Billion in 2018, and is expected to generate revenue of around USD 25.07 Billion by end of 2025, growing at a CAGR of around 8.2 % between 2018 and 2025.
People are abussing substances like alcohol, tobacco and other drugs for a variety of complicated reasons, but it is clear that the society is paying a significant cost. The Substance Abuse and Mental Health Services Administration (SAMHSA) estimated in 2015 that nearly 22 million people at least 12 years of age needed treatment for substance abuse.Drug abuse treatment plans not only help addicts detoxify in a safe environment, but also help them through all stages of the recovery process. In the management of drug abuse and addiction issues, different treatment methodologies are used.
The study provides a decisive view on the Substance Abuse Treatment market by segmenting the market based on Abuse Type, Treatment Type and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Abuse Type, the market is segmented into Alcohol dependence, Tobacco/Nicotine addiction, Drug abuse and others. It is expected that drug abuse segment accounts for maximum share in the Substance Abuse Treatment market owing to the increasing addiction of opiods. Based on Treatment Type, the market is segmented into Alcohol addiction treatment, Tobacco/Nicotine addiction treatment, Drug abuse treatment and Others. Alcohol addiction treatment segment is anticipated to have a highest growth rate with respect to value.
The geographical segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America led the market with regard to revenue owing to the presence of major players in the region and increasing awareness about the substance abuse treatment. Recently, different private and government agencies have launches substance abuse treatment campaigns. Europe is the second in terms of revenue attributing to the increase in investments for research and Developments.
Factors such as increased awareness of patients, higher rate of seeking treatment, increased government intervention and encouragement to curb substance abuse in all countries are driving the growth of the global market for substance abuse treatment. It is observed that the market for nicotine addiction treatment held the largest market share because the increased number of addicted tobacco populations, the increased number of approved medicines and the increased use of nicotine with other stimulants affect the growth of the global market for nicotine addiction treatment. Drug awareness initiatives, as well as associated prevention programs, include a rise in patient awareness, an increase in the rate of treatment-seeking driven by increases in government intervention, and an increased focus on curbing misuse of drugs in many countries. Successful treatment for substance abuse has been growing with new drugs that avoid relapse and regulate drug cravings as well. Such factors may play a role in the future growth of the sector.
Key players within global Substance Abuse Treatment market include Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma and Teva Pharmaceutical amongst others.
The report segments global Substance Abuse Treatment market as follows:
Global Substance Abuse Treatment Market: Abuse Type Segment Analysis
Global Substance Abuse Treatment Market: Treatment Type Segment Analysis
Global Substance Abuse Treatment Market: Regional Segment Analysis
According to the report, global demand for meningococcal vaccines Market was valued at approximately USD 14.44 Billion in 2018, and is expected to generate revenue of around USD 25.07 Billion by end of 2025, growing at a CAGR of around 8.2 % between 2018 and 2025.
People are abussing substances like alcohol, tobacco and other drugs for a variety of complicated reasons, but it is clear that the society is paying a significant cost. The Substance Abuse and Mental Health Services Administration (SAMHSA) estimated in 2015 that nearly 22 million people at least 12 years of age needed treatment for substance abuse.Drug abuse treatment plans not only help addicts detoxify in a safe environment, but also help them through all stages of the recovery process. In the management of drug abuse and addiction issues, different treatment methodologies are used.
The study provides a decisive view on the Substance Abuse Treatment market by segmenting the market based on Abuse Type, Treatment Type and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Abuse Type, the market is segmented into Alcohol dependence, Tobacco/Nicotine addiction, Drug abuse and others. It is expected that drug abuse segment accounts for maximum share in the Substance Abuse Treatment market owing to the increasing addiction of opiods. Based on Treatment Type, the market is segmented into Alcohol addiction treatment, Tobacco/Nicotine addiction treatment, Drug abuse treatment and Others. Alcohol addiction treatment segment is anticipated to have a highest growth rate with respect to value.
The geographical segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America led the market with regard to revenue owing to the presence of major players in the region and increasing awareness about the substance abuse treatment. Recently, different private and government agencies have launches substance abuse treatment campaigns. Europe is the second in terms of revenue attributing to the increase in investments for research and Developments.
Factors such as increased awareness of patients, higher rate of seeking treatment, increased government intervention and encouragement to curb substance abuse in all countries are driving the growth of the global market for substance abuse treatment. It is observed that the market for nicotine addiction treatment held the largest market share because the increased number of addicted tobacco populations, the increased number of approved medicines and the increased use of nicotine with other stimulants affect the growth of the global market for nicotine addiction treatment. Drug awareness initiatives, as well as associated prevention programs, include a rise in patient awareness, an increase in the rate of treatment-seeking driven by increases in government intervention, and an increased focus on curbing misuse of drugs in many countries. Successful treatment for substance abuse has been growing with new drugs that avoid relapse and regulate drug cravings as well. Such factors may play a role in the future growth of the sector.
Key players within global Substance Abuse Treatment market include Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma and Teva Pharmaceutical amongst others.
The report segments global Substance Abuse Treatment market as follows:
Global Substance Abuse Treatment Market: Abuse Type Segment Analysis
- Alcohol dependence
- Tobacco/Nicotine addiction
- Drug abuse
- Others
Global Substance Abuse Treatment Market: Treatment Type Segment Analysis
- Alcohol Addiction Treatment
- Tobacco/Nicotine Addiction Treatment
- Drug Abuse Treatment
- Others
Global Substance Abuse Treatment Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Substance Abuse Treatment Market, 2016 - 2025, (USD Million)
- 2.2. Substance Abuse Treatment Market: Snapshot
- Chapter 3. Global Substance Abuse Treatment Market - Industry Analysis
- 3.1. Substance Abuse Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing addiction of opiods
- 3.3. Restraints
- 3.3.1. Regulatory stringency
- 3.4. Opportunity
- 3.4.1. Government funding and support
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Abuse Type segment
- 3.6.2. Market attractiveness analysis by Treatment Type segment
- 3.6.3. Market attractiveness analysis by regional segment
- Chapter 4. Global Substance Abuse Treatment Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Substance Abuse Treatment market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New product launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Substance Abuse Treatment Market -Abuse Type Segment Analysis
- 5.1. Global Substance Abuse Treatment market overview: by Abuse Type
- 5.1.1. Global Substance Abuse Treatment market revenue share, by Abuse Type, 2018 and 2025
- 5.2. Alcohol dependence
- 5.2.1. Global Substance Abuse Treatment market by Alcohol dependence, 2016-2025 (USD Million)
- 5.3. Tobacco/Nicotine addiction
- 5.3.1. Global Substance Abuse Treatment market by Tobacco/Nicotine addiction, 2016-2025 (USD Million)
- 5.4. Drug abuse
- 5.4.1. Global Substance Abuse Treatment market by Drug abuse, 2016-2025 (USD Million)
- 5.5. Others
- 5.5.1. Global Substance Abuse Treatment market by Others, 2016-2025 (USD Million)
- 5.1. Global Substance Abuse Treatment market overview: by Abuse Type
- Chapter 6. Global Substance Abuse Treatment Market - Treatment Type Segment Analysis
- 6.1. Global Substance Abuse Treatment market overview: by Treatment Type
- 6.1.1. Global Substance Abuse Treatment market revenue share, by Treatment Type, 2018 and 2025
- 6.2. Alcohol Addiction Treatment
- 6.2.1. Global Substance Abuse Treatment market by Alcohol Addiction Treatment, 2016-2025 (USD Million)
- 6.3. Tobacco/Nicotine Addiction Treatment
- 6.3.1. Global Substance Abuse Treatment market by Tobacco/Nicotine Addiction Treatment, 2016-2025 (USD Million)
- 6.4. Drug Abuse Treatment
- 6.4.1. Global Substance Abuse Treatment market by Drug Abuse Treatment, 2016-2025 (USD Million)
- 6.5. Others
- 6.5.1. Global Substance Abuse Treatment market by others, 2016-2025 (USD Million)
- 6.1. Global Substance Abuse Treatment market overview: by Treatment Type
- Chapter 7. Global Substance Abuse Treatment Market - Regional Analysis
- 7.1. Global Substance Abuse Treatment market overview: by region
- 7.1.1. Global Substance Abuse Treatment market revenue share, by region, 2018 and 2025
- 7.2. North America
- 7.2.1. North America Substance Abuse Treatment market, by country, 2016-2025 (USD Million)
- 7.2.2. North America Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.2.3. North America Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.2.4. The U.S.
- 7.2.4.1. The U.S. Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.2.4.2. The U.S. Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.2.5.2. Rest of North America Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Substance Abuse Treatment market, by country, 2016-2025 (USD Million)
- 7.3.2. Europe Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.3.3. Europe Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.3.4. U.K.
- 7.3.4.1. U.K. Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.3.4.2. U.K. Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.3.5. France
- 7.3.5.1. France Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.3.5.2. France Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.3.6. Germany
- 7.3.6.1. Germany Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.3.6.2. Germany Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.3.7.2. Rest of Europe Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Substance Abuse Treatment market, by country, 2016-2025 (USD Million)
- 7.4.2. Asia Pacific Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.4.3. Asia Pacific Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.4.4. China
- 7.4.4.1. China Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.4.4.2. China Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.4.5. Japan
- 7.4.5.1. Japan Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.4.5.2. Japan Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.4.6. India
- 7.4.6.1. India Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.4.6.2. India Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.4.7.2. Rest of Asia Pacific Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Substance Abuse Treatment market, by country, 2016-2025 (USD Million)
- 7.5.2. Latin America Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.5.3. Latin America Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.5.4.2. Brazil Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.5.5. Rest of Latin America
- 7.5.5.1. Rest of Latin America Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.5.5.2. Rest of Latin America Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Middle East & Africa Substance Abuse Treatment market, 2016-2025 (USD Million)
- 7.6.2. Middle East & Africa Substance Abuse Treatment market revenue, by Abuse Type, 2016-2025 (USD Million)
- 7.6.3. Middle East & Africa Substance Abuse Treatment market revenue, by Treatment Type, 2016-2025 (USD Million)
- 7.1. Global Substance Abuse Treatment market overview: by region
- Chapter 8. Company Profiles
- 8.1. Accord Healthcare
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Amphastar Pharmaceuticals
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Apotex
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. BioCorRx
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Cipla
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Developments
- 8.6. Glenmark
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Developments
- 8.7. INSYS Therapeutics
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Developments
- 8.8. LFB Group
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Developments
- 8.9. Lupin
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Developments
- 8.10. Mylan Laboratories
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Developments
- 8.11. Opiant Technologies
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategy
- 8.11.5. Recent Developments
- 8.12. Sanofi Aventis
- 8.12.1. Overview
- 8.12.2. Financials
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategy
- 8.12.5. Recent Developments
- 8.13. Sanquin
- 8.13.1. Overview
- 8.13.2. Financials
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategy
- 8.13.5. Recent Developments
- 8.14. Sterinova
- 8.14.1. Overview
- 8.14.2. Financials
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategy
- 8.14.5. Recent Developments
- 8.15. Sun Pharma
- 8.15.1. Overview
- 8.15.2. Financials
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategy
- 8.15.5. Recent Developments
- 8.16. Teva Pharmaceutical
- 8.16.1. Overview
- 8.16.2. Financials
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategy
- 8.16.5. Recent Developments
- 8.1. Accord Healthcare
